CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Details 3) (USD $)	4 Months Ended				5 Months Ended	12 Months Ended		5 Months Ended	12 Months Ended		5 Months Ended	12 Months Ended		5 Months Ended	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2012 AMCE	Dec. 31, 2012 Subsidiary Guarantors	Dec. 31, 2012 Subsidiary Non-Guarantors	Aug. 30, 2012 Predecessor	Mar. 29, 2012 Predecessor	Mar. 31, 2011 Predecessor	Aug. 30, 2012 Predecessor AMCE	Mar. 29, 2012 Predecessor AMCE	Mar. 31, 2011 Predecessor AMCE	Aug. 30, 2012 Predecessor Subsidiary Guarantors	Mar. 29, 2012 Predecessor Subsidiary Guarantors	Mar. 31, 2011 Predecessor Subsidiary Guarantors	Aug. 30, 2012 Predecessor Subsidiary Non-Guarantors	Mar. 29, 2012 Predecessor Subsidiary Non-Guarantors	Mar. 31, 2011 Predecessor Subsidiary Non-Guarantors
Cash flows from operating activities:
Net cash provided by (used in) operating activities	$ 73,892,000	$ (21,605,000)	$ 143,430,000	$ (47,933,000)	$ 79,497,000	$ 197,327,000	$ 92,072,000	$ (3,735,000)	$ 21,673,000	$ 47,587,000	$ 82,423,000	$ 177,633,000	$ 44,144,000	$ 809,000	$ (1,979,000)	$ 341,000
Cash flows from investing activities:
Acquisition of Kerasotes, net of cash acquired							(280,606,000)						(280,606,000)
Proceeds from NCM, Inc. stock sale							102,224,000						102,224,000
Capital expenditures	(72,774,000)		(72,765,000)	(9,000)	(40,116,000)	(139,359,000)	(129,347,000)				(40,095,000)	(139,195,000)	(128,952,000)	(21,000)	(164,000)	(395,000)
Merger	3,110,000		3,110,000
Acquisition of Rave theatres, net of cash acquired	(87,555,000)		(87,555,000)
Proceeds from disposition of long-term assets	90,000		112,000	(22,000)	7,291,000	1,474,000	58,391,000				7,134,000	1,474,000	58,391,000	157,000
Investments in non-consolidated entities, net					1,589,000	(26,880,000)	(1,619,000)		1,049,000		(17,000)	(27,928,000)	(1,819,000)	1,606,000	(1,000)	200,000
Proceeds from sale and lease back of digital projectors						953,000	4,905,000					953,000	4,905,000
Investments in non-consolidated entities, net	(1,194,000)		(1,173,000)	(21,000)
Other, net	(575,000)		(575,000)		205,000	98,000	(5,825,000)				205,000	98,000	(5,825,000)
Proceeds from disposition of Cinemex							1,840,000						1,840,000
Net cash (used in) investing activities	(158,898,000)		(158,846,000)	(52,000)	(31,031,000)	(163,714,000)	(250,037,000)		1,049,000		(32,773,000)	(164,598,000)	(249,842,000)	1,742,000	(165,000)	(195,000)
Cash flows from financing activities:
Proceeds from issuance of Senior Subordinated Notes due 2020							600,000,000			600,000,000
Repurchase of Senior Subordinated Notes due 2016							(325,000,000)			(325,000,000)
Payment of tender offer and consent solicitation consideration on Senior Subordinated Notes due 2016							(5,801,000)			(5,801,000)
Proceeds from issuance of Term Loan due 2018						297,000,000			297,000,000
Repayment of Term Loan due 2013						(140,657,000)			(140,657,000)
Repurchase of Senior Subordinated Notes due 2014					(191,035,000)	(108,965,000)		(191,035,000)	(108,965,000)
Principal payments under Term Loan	(4,002,000)	(4,002,000)			(4,002,000)	(4,875,000)	(6,500,000)	(4,002,000)	(4,875,000)	(6,500,000)
Principal payments under capital and financing lease obligations	(875,000)		(875,000)		(1,298,000)	(3,422,000)	(4,194,000)				(1,298,000)	(3,422,000)	(4,194,000)
Capital contribution	100,000,000	100,000,000
Deferred financing costs					(2,378,000)	(6,002,000)	(14,642,000)	(2,378,000)	(6,002,000)	(14,642,000)
Change in construction payables	22,487,000		22,487,000		(23,575,000)	13,512,000	(727,000)				(23,575,000)	13,512,000	(727,000)
Change in intercompany advances		(74,376,000)	23,867,000	50,509,000				200,755,000	51,044,000	(17,386,000)	(200,872,000)	(52,427,000)	16,623,000	117,000	1,383,000	763,000
Dividends paid to Parent						(109,581,000)	(278,258,000)		(109,581,000)	(278,258,000)
Net cash used in financing activities	117,610,000	21,622,000	45,479,000	50,509,000	(222,288,000)	(62,990,000)	(35,122,000)	3,340,000	(22,036,000)	(47,587,000)	(225,745,000)	(42,337,000)	11,702,000	117,000	1,383,000	763,000
Effect of exchange rate changes on cash and equivalents	(207,000)		3,779,000	(3,986,000)	16,000	556,000	(1,098,000)				(588,000)	215,000	(150,000)	604,000	341,000	(948,000)
Net increase (decrease) in cash and equivalents	32,397,000	17,000	33,842,000	(1,462,000)	(173,806,000)	(28,821,000)	(194,185,000)	(395,000)	686,000		(176,683,000)	(29,087,000)	(194,146,000)	3,272,000	(420,000)	(39,000)
Cash and equivalents at beginning of period	98,531,000	291,000	55,326,000	42,914,000	272,337,000	301,158,000	495,343,000	686,000			232,009,000	261,096,000	455,242,000	39,642,000	40,062,000	40,101,000
Cash and equivalents at end of period	$ 130,928,000	$ 308,000	$ 89,168,000	$ 41,452,000		$ 272,337,000	$ 301,158,000	$ 291,000	$ 686,000		$ 55,326,000	$ 232,009,000	$ 261,096,000	$ 42,914,000	$ 39,642,000	$ 40,062,000